Community hub
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something to knowledge base
Welcome to the community hub built to collect knowledge and have discussions related to Dibekacin.
Content stats: 0 posts, 0 articles, 1 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Dibekacin AI simulator
(@Dibekacin_simulator)
Hub AI
Dibekacin AI simulator
(@Dibekacin_simulator)
Dibekacin
Dibekacin (3',4'-dideoxykanamycin B) is an aminoglycoside antibiotic. It is a semisynthetic derivative of kanamycin developed by Hamao Umezawa and collaborators for Meiji Seika.
It has been used in combination with sulbenicillin.
Dibekacin
Dibekacin (3',4'-dideoxykanamycin B) is an aminoglycoside antibiotic. It is a semisynthetic derivative of kanamycin developed by Hamao Umezawa and collaborators for Meiji Seika.
It has been used in combination with sulbenicillin.
Recent media
Recent media